Long-term follow-up of patients undergoing laparoscopic surgery for phaeochromocytoma
- PMID: 35754193
- PMCID: PMC9234194
- DOI: 10.1093/bjsopen/zrac076
Long-term follow-up of patients undergoing laparoscopic surgery for phaeochromocytoma
Abstract
Introduction: Phaeochromocytomas are rare tumours with a recurrence after open surgery ranging between 6-23 per cent. Long-term follow-up studies after laparoscopic surgery for phaeochromocytoma are lacking. The aim of this study was to look at the long-term oncological outcome of a consecutive series of patients from a single centre undergoing laparoscopic surgery for a phaeochromocytoma.
Methods: Demographic data on all patients with an adrenal tumour or paraganglioma were prospectively kept on a database between September 1999 and December 2017. Electronic hospital records, including imaging from a national linked archiving and communication system, were reviewed for patients with a phaeochromocytoma in November 2021.
Results: During the study interval 135 patients with a phaeochromocytoma were operated on in the unit, of which 118 (87.4 per cent) were attempted laparoscopically. Five (4.2 per cent) were converted to open surgery, whereas 117 had a potentially curative operation. There was no peri- or postoperative mortality. At a median follow-up of 10 (interquartile range 6-12.9) years, only 3 (2.6 per cent) patients died from metastatic phaeochromocytoma. One further patient developed lymph node metastases, which were removed at open surgery. No patient had a local recurrence and the only significant predictor of recurrence was the presence of lymph node metastases (P < 0.001). Two patients developed a contralateral adrenal phaeochromocytoma, while one of these also had a paraganglioma. The Kaplan-Meier estimate of phaeochromocytoma-free survival was 96 per cent (95 per cent c.i. 92.2 to 98.8) at 5 years and 92 per cent (95 per cent c.i. 86.7 to 97.3) at 10 years.
Conclusion: This study demonstrates that long-term oncological outcomes of laparoscopic surgery for patients with a phaeochromocytoma are at least as good as that with an open operation.
© The Author(s) 2022. Published by Oxford University Press on behalf of BJS Society Ltd.
Figures
References
-
- Tormey WP. Milestones in the evolution of phaechromocytoma diagnosis. J Ir Coll Physicians Surg 2002;31:222–231 - PubMed
-
- Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre Oet al. . Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812–8818 - PubMed
-
- Modlin IM, Farndon JR, Shepard A, Johnston IDA, Kennedy TL, Montgomery DADet al. . Phaechromocytomas in 72 patients: clinical and diagnostic features, treatment and long-term results. Br J Surg 1979;66:456–465 - PubMed
-
- Scott HW Jr, Halter SA. Oncologic aspects of pheochromocytoma: the importance of follow up. Surgery 1984;96:1061–1066 - PubMed
-
- van Heerdan JA, Roland CF, Carney JA, Sheps JA, Grant CS. Long-term evaluation following resection of apparently benign pheochromocytoma(s) or paraganglioma(s). World J Surg 1990;14:325–329 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical